Rockwell Medical, Inc.
Hedge Funds Holdings
Last updated:
Rockwell Medical, Inc.‘s stocks are currently a part of 21 hedge funds’ portfolios, which represents 11.35% of the total amount of its stocks outstanding. This makes up a total of 1.12M shares of Rockwell Medical, Inc.. Compared to the previous quarter, the number fell by -61.01% or -1.75M shares fewer. As for the holding position changes, 23.81% (5) of current hedge fund investors increased the number of shares held, 42.86% (9) of current holders sold a part of the shares held, and 9.52% (2) closed the holdings completely. 4 hedge funds are new holders of Rockwell Medical, Inc. stock in Q1 2023, it is 19.05% of total holders.
Hedge funds holding Rockwell Medical (Q2 2018 – Q1 2023)
Q2 2018 | 85 |
---|---|
Q3 2018 | 79 |
Q4 2018 | 83 |
Q1 2019 | 82 |
Q2 2019 | 95 |
Q3 2019 | 87 |
Q4 2019 | 81 |
Q1 2020 | 77 |
Q2 2020 | 78 |
Q3 2020 | 85 |
Q4 2020 | 87 |
Q1 2021 | 87 |
Q2 2021 | 73 |
Q3 2021 | 59 |
Q4 2021 | 54 |
Q1 2022 | 49 |
Q2 2022 | 29 |
Q3 2022 | 30 |
Q4 2022 | 30 |
Q1 2023 | 21 |
Hedge funds changes in Rockwell Medical positions (Q2 2018 – Q1 2023)
Q2 2018 | 11 | 24 | 24 | 8 | 18 |
---|---|---|---|---|---|
Q3 2018 | 5 | 28 | 25 | 10 | 11 |
Q4 2018 | 9 | 27 | 25 | 5 | 17 |
Q1 2019 | 9 | 26 | 19 | 10 | 18 |
Q2 2019 | 24 | 33 | 15 | 7 | 16 |
Q3 2019 | 10 | 32 | 21 | 19 | 5 |
Q4 2019 | 10 | 28 | 19 | 15 | 9 |
Q1 2020 | 8 | 31 | 17 | 10 | 11 |
Q2 2020 | 12 | 26 | 16 | 11 | 13 |
Q3 2020 | 18 | 20 | 26 | 11 | 10 |
Q4 2020 | 12 | 35 | 19 | 11 | 10 |
Q1 2021 | 10 | 24 | 25 | 10 | 18 |
Q2 2021 | 10 | 13 | 27 | 22 | 1 |
Q3 2021 | 2 | 9 | 21 | 18 | 9 |
Q4 2021 | 7 | 6 | 16 | 12 | 13 |
Q1 2022 | 5 | 13 | 11 | 10 | 10 |
Q2 2022 | 29 | 0 | 0 | 49 | -49 |
Q3 2022 | 6 | 6 | 10 | 5 | 3 |
Q4 2022 | 4 | 11 | 8 | 2 | 5 |
Q1 2023 | 4 | 5 | 9 | 2 | 1 |
Hedge funds changes in Rockwell Medical stock options (Q2 2018 – Q1 2023)
Q2 2018 | 1,644,000 | 2,485,000 |
---|---|---|
Q3 2018 | 503,000 | 1,584,000 |
Q4 2018 | 274,000 | 558,000 |
Q1 2019 | 2,160,000 | 1,212,000 |
Q2 2019 | 755,000 | 514,000 |
Q3 2019 | 255,000 | 528,000 |
Q4 2019 | 0 | 261,000 |
Q1 2020 | 419,000 | 356,000 |
Q2 2020 | 193,000 | 242,000 |
Q3 2020 | 128,000 | 87,000 |
Q4 2020 | 69,000 | 0 |
Q1 2021 | 559,000 | 166,000 |
Q2 2021 | 329,000 | 90,000 |
Q3 2021 | 202,000 | 89,000 |
Q4 2021 | 7,000 | 5,000 |
Q1 2022 | 52,000 | 1,000 |
Q2 2022 | 112,000 | 16,000 |
Q3 2022 | 45,000 | 0 |
Q4 2022 | 1,523 | 305 |
Q1 2023 | 0 | 0 |